INTERVIEW: Dr JAME ABRAHAM
CHAIRMAN, DEPARTMENT OF HEMATOLOGY AND MEDICAL ONCOLOGY, CLEVELAND CLINIC
Or, was it because of the stubborn nature of the disease, quite like how a crab doesn't let go of you easily when it bites? Cancer continues to baffle and fascinate us, much like the origin of the word. But we surely have come a long way in understanding and treating it. Now, with artificial intelligence, there is new hope, says Dr Jame Abraham of Cleveland Clinic. As someone heading the department of hematology and medical oncology, he has seen both the human and clinical side of fighting cancer. In an interview with THE WEEK, Abraham, whose latest book-Cleveland Notes traces his journey as a cancer physician, talks about how new therapies are changing cancer care.
Q CAR T-cell therapy has revolutionised cancer care. Most drugs today work on activating the immune system to attack cancer cells. How big a difference has the therapy made in treating different kinds of cancer?
A Training our immune system to attack cancer cells without causing damage to normal cells is one of the most important advances in cancer therapy in the past 10 years. Various immunotherapy approaches including monoclonal antibodies, such as pembrolizumab, and CAR T-cell therapy are currently saving patients’ lives. Immunotherapy has improved survival in advanced melanoma and lung cancer—two of the most lethal cancer diagnosis. In August 2015, former US president Jimmy Carter was diagnosed with metastatic melanoma that had spread to his brain. He was treated with pembrolizumab (immunotherapy) and has been in remission for the past eight years, which is a remarkable achievement. Similarly, CAR T-cell therapy is offering long-term remission in advanced myeloma and lymphoma diagnosis.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
What Will It Take To Clean Up Delhi Air?
IT IS ASKED, year after year, why Delhi’s air remains unbreathable despite several interventions to reduce pollution.
Trump and the crisis of liberalism
Although Donald Trump's election to a non-consecutive second term to the US presidency is not unprecedented—Grover Cleveland had done it in 1893—it is nevertheless a watershed moment.
Men eye the woman's purse
A couple of months ago, I chanced upon a young 20-something man at my gym walking out with a women’s sling bag.
When trees hold hands
A filmmaker explores the human-nature connect through the living root bridges
Ms Gee & Gen Z
The vibrant Anuja Chauhan and her daughter Nayantara on the generational gap in romance writing
Vikram Seth-a suitable man
Our golden boy of literature was the star attraction at the recent Shillong Literary Festival in mysterious Meghalaya.
Superman bites the dust
When my granddaughter Kim was about three, I often took her to play in a nearby park.
OLD MAN AND THE SEA
Meet G. Govinda Menon, the 102-year-old engineer who had a key role in surveying the Vizhinjam coast in the 1940s, assessing its potential for an international port
Managing volatility: smarter equity choices in uncertain markets
THE INDIAN STOCK MARKET has delivered a strong 11 per cent CAGR over the past decade, with positive returns for eight straight years.
Investing in actively managed low-volatility portfolios keeps risks at bay
AFTER A ROARING bull market over the past year, equity markets in the recent months have gone into a correction mode as FIIs go on a selling spree. Volatility has risen and investment returns are hurt.
